Publicaciones (35) Publicaciones de JOSÉ CARLOS PLAZA HERNÁNDEZ

2024

  1. Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach

    Archives of pathology & laboratory medicine, Vol. 148, Núm. 3, pp. 318-326

  2. Increased Levels of Phosphorylated-P38α Induce WNT/β-Catenin and NGF/P75NTR/TrkA Pathways Disruption and SN56 Cell Death following Single and Repeated Chlorpyrifos Treatment

    Foods, Vol. 13, Núm. 15

2023

  1. Clinical Behavior, Mutational Profile and T-Cell Repertoire of High-Grade Neuroendocrine Tumors of the Head and Neck

    Cancers, Vol. 15, Núm. 9

  2. Durable complete remission with local therapies after neoadjuvant and adjuvant nivolumab in recurrent/metastatic head and neck cancer

    Anti-Cancer Drugs, Vol. 34, Núm. 5, pp. 695-698

  3. Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer

    Oncology Letters, Vol. 25, Núm. 1

2021

  1. Major pathological response and durable locoregional control after neoadjuvant pembrolizumab-carboplatin-paclitaxel in head and neck cancer

    Oral Oncology

2020

  1. A prospective observational study of the clinical and pathological impact of stereotactic body radiotherapy (SBRT) as a neoadjuvant strategy of chemoradiation in pancreatic cancer

    Clinical and Translational Oncology, Vol. 22, Núm. 9, pp. 1499-1505

2019

  1. Clinical presentation and anatopathologic finding of a hepatic vascular hamartoma: A case report

    Annals of Hepatology, Vol. 18, Núm. 1, pp. 225-229

  2. Impact of brca1/2 gene mutations on survival of patients with pancreatic cancer: A case-series analysis

    Annals of Hepato-Biliary-Pancreatic Surgery, Vol. 23, Núm. 2, pp. 200-205

  3. Implementation of a Pancreatic Cancer Treatment Selection Program Based on a Real-time Biomarker Analysis in Available Biopsies.

    British Journal of Pharmaceutical and Medical Research, Vol. 04

  4. Quantitative analysis of 18-FDG-PET/MRI to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. A prospective preliminary study

    Acta Oncologica

  5. Venous Resection for Locally Advanced Pancreatic Cancer: Time Trend and Outcome Analysis of 65 Consecutive Resections at a High-Volume Center

    Surgical technology international, Vol. 35, pp. 92-99

  6. Venous resection for locally advanced pancreatic cancer: Time trend and outcome analysis of 65 consecutive resections at a high-volume center

    Surgical Technology International, Vol. 35, pp. 1-8

2018

  1. Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab

    Oncologist, Vol. 23, Núm. 9, pp. 1092-1102

2017

  1. A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma

    Surgical Oncology, Vol. 26, Núm. 4, pp. 402-410

  2. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain

    Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681

  3. Hepatobilio-pancreatic robotic surgery: initial experience from a single center institute

    Journal of Robotic Surgery, Vol. 11, Núm. 3, pp. 355-365

  4. Surgery for pancreatic ductal adenocarcinoma

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1303-1311

2016

  1. Full robot-assisted gastrectomy: surgical technique and preliminary experience from a single center

    Journal of Robotic Surgery, Vol. 10, Núm. 4, pp. 297-306

  2. Pancreatic disease, panniculitis, polyarthrtitis syndrome successfully treated with total pancreatectomy: Case report and literature review

    International Journal of Surgery Case Reports, Vol. 28, pp. 223-226